Perry Elliott

Summary

Affiliation: University College London
Country: UK

Publications

  1. pmc Quantification of left ventricular trabeculae using fractal analysis
    Gabriella Captur
    Division of Cardiovascular Imaging, The Heart Hospital, part of University College London NHS Foundation Trust, 16 18 Westmoreland Street, London, W1G 8PH, UK
    J Cardiovasc Magn Reson 15:36. 2013
  2. doi request reprint A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients wi
    Constantinos O'Mahony
    The Inherited Cardiac Diseases Unit, The Heart Hospital University College London, 16 18 Westmoreland Street, London, UK
    Heart 99:534-41. 2013
  3. pmc Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
    Luis R Lopes
    The Heart Hospital, 16 18 Westmoreland Street, London W1G 8PH, UK
    J Med Genet 50:228-39. 2013
  4. doi request reprint Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey
    Perry Elliott
    he Heart Hospital, University College London, London, UK
    Heart 97:1957-60. 2011
  5. doi request reprint The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
    Constantinos O'Mahony
    The Heart Hospital, 16 18 Westmoreland Street, London, UK
    Heart 98:116-25. 2012
  6. doi request reprint Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy
    Perry Elliott
    Inherited Cardiac Diseases Unit, University College London The Heart Hospital UCL Hospitals NHS trust, London, UK
    Circ Cardiovasc Genet 3:314-22. 2010
  7. doi request reprint The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy
    Constantinos O'Mahony
    Inherited Cardiac Diseases Unit, The Heart Hospital University College London, 16 18 Westmoreland Street, London W1G 8PH, UK
    Europace 14:724-33. 2012
  8. doi request reprint Anderson-Fabry disease and the heart
    Constantinos O'Mahony
    Inherited Cardiac Diseases Unit, The Heart Hospital, University College London, UK
    Prog Cardiovasc Dis 52:326-35. 2010
  9. doi request reprint Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene
    Ferdinando Pasquale
    Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom
    Circ Cardiovasc Genet 5:10-7. 2012
  10. doi request reprint Beyond sudden death in the athlete: how to identify family members at risk
    Giovanni Quarta
    The Heart Hospital, 16 18 Westmoreland Street, London W1G 8PH, UK
    Br J Sports Med 45:189-92. 2011

Collaborators

Detail Information

Publications21

  1. pmc Quantification of left ventricular trabeculae using fractal analysis
    Gabriella Captur
    Division of Cardiovascular Imaging, The Heart Hospital, part of University College London NHS Foundation Trust, 16 18 Westmoreland Street, London, W1G 8PH, UK
    J Cardiovasc Magn Reson 15:36. 2013
    ....
  2. doi request reprint A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients wi
    Constantinos O'Mahony
    The Inherited Cardiac Diseases Unit, The Heart Hospital University College London, 16 18 Westmoreland Street, London, UK
    Heart 99:534-41. 2013
    ....
  3. pmc Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
    Luis R Lopes
    The Heart Hospital, 16 18 Westmoreland Street, London W1G 8PH, UK
    J Med Genet 50:228-39. 2013
    ....
  4. doi request reprint Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey
    Perry Elliott
    he Heart Hospital, University College London, London, UK
    Heart 97:1957-60. 2011
    ..The aim of this study was to determine the prevalence of AFD in a large, consecutive cohort of patients with hypertrophic cardiomyopathy (HCM) using rapid mutation screening...
  5. doi request reprint The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
    Constantinos O'Mahony
    The Heart Hospital, 16 18 Westmoreland Street, London, UK
    Heart 98:116-25. 2012
    ....
  6. doi request reprint Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy
    Perry Elliott
    Inherited Cardiac Diseases Unit, University College London The Heart Hospital UCL Hospitals NHS trust, London, UK
    Circ Cardiovasc Genet 3:314-22. 2010
    ..The objective of this study was to determine the prevalence of mutations in 5 desmosomal protein genes in patients with dilated cardiomyopathy...
  7. doi request reprint The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy
    Constantinos O'Mahony
    Inherited Cardiac Diseases Unit, The Heart Hospital University College London, 16 18 Westmoreland Street, London W1G 8PH, UK
    Europace 14:724-33. 2012
    ....
  8. doi request reprint Anderson-Fabry disease and the heart
    Constantinos O'Mahony
    Inherited Cardiac Diseases Unit, The Heart Hospital, University College London, UK
    Prog Cardiovasc Dis 52:326-35. 2010
    ....
  9. doi request reprint Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene
    Ferdinando Pasquale
    Heart Hospital, Institute of Cardiovascular Sciences, University College London, London, United Kingdom
    Circ Cardiovasc Genet 5:10-7. 2012
    ..However, previous studies are limited by sample size, cross-sectional design, and few data in relatives...
  10. doi request reprint Beyond sudden death in the athlete: how to identify family members at risk
    Giovanni Quarta
    The Heart Hospital, 16 18 Westmoreland Street, London W1G 8PH, UK
    Br J Sports Med 45:189-92. 2011
    ..We show that a systematic approach to the clinical evaluation of relatives of sudden death victims has a high yield in the identification of other affected family members and may prevent further catastrophic events in the same family...
  11. doi request reprint A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy
    Mary N Sheppard
    Department of Histopathology, Royal Brompton and Harefield NHS Trust, London, UK
    Cardiovasc Pathol 19:293-301. 2010
    ..Pathologic data examining the effect of enzyme replacement therapy (ERT) in vivo are scant...
  12. doi request reprint Hypertrophic cardiomyopathy: a 50th anniversary. Preface
    Perry Elliott
    The Heart Hospital, 16 18 Westmoreland Street, London W1G 8PH, UK
    Heart 94:1247-8. 2008
  13. ncbi request reprint Sudden death in athletes
    Vimal Patel
    The Heart Hospital, University College London
    Clin Med 12:253-6. 2012
    ..This article will review the aetiology of sudden cardiac death and will present the evidence for pre-participation screening...
  14. doi request reprint Provokable left ventricular outflow tract obstruction in a patient without hypertrophy
    Ferdinando Pasquale
    The Heart Hospital, London, UK
    Nat Rev Cardiol 6:313-6. 2009
    ..He had been diagnosed as having hiatus hernia 2 years previously and was taking proton-pump inhibitors as necessary. He had a family history of ischemic heart disease and subarachnoid hemorrhage...
  15. ncbi request reprint Investigation and treatment of hypertrophic cardiomyopathy
    Perry Elliott
    The Heart Hospital, University College, London
    Clin Med 7:383-7. 2007
    ..Genetic counselling and clinical risk stratification are relevant for all patients. Subsets of patients require septal alcohol ablation, septal myectomy and implantable cardioverter defibrillators...
  16. ncbi request reprint Hypertrophic cardiomyopathy
    Perry Elliott
    University College London, London, UK
    Lancet 363:1881-91. 2004
    ..We review the management of patients with unexplained myocardial hypertrophy, considering the influence of underlying genetic and pathophysiological substrates on clinical decision-making...
  17. ncbi request reprint B Embryogenesis of Ventricular Myocardial Trabeculae - Novel Insights from Episcopic 3D Imaging and Fractal Analysis of Wild-type and Notch MIB1 Noncompaction Mouse Models
    Gabriella Captur
    Institute of Cardiovascular Science, University College London, London, UKThe Inherited Cardiovascular Diseases Unit and Cardiac Imaging Department, The Heart Hospital, London, UK
    Heart 100:A125-8. 2014
    ....
  18. ncbi request reprint The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy
    Juan Pablo Kaski
    The Heart Hospital, University College London, UK
    Herz 32:446-51. 2007
    ..In this article, this is illustrated by examples of dilated cardiomyopathy as familial/genetic forms and nonfamilial/nongenetic forms...
  19. ncbi request reprint Optimization of concomitant medication in Fabry cardiomyopathy
    Lydia Close
    The Heart Hospital, University College, London, UK
    Acta Paediatr Suppl 96:81-3. 2007
    ..CONCLUSION: In the era of enzyme replacement therapy, conventional pharmacological and device-based therapies remain central to the management of cardiovascular symptoms and the prevention of complications, such as arrhythmia and stroke...
  20. ncbi request reprint Cardiac resynchronization therapy: the procedure and progress so far
    Sanjay K Kohli
    Inherited Cardiovascular Disease Unit, The Heart Hospital, University College London, London W1G 8PH
    Br J Hosp Med (Lond) 66:469-73. 2005
  21. ncbi request reprint Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy
    Elijah R Behr
    Cardiological Sciences, St George s Hospital Medical School, Tooting, London, UK
    Card Electrophysiol Rev 6:482-6. 2002
    ..Appropriate management may then involve radiofrequency ablation. A permanent pacemaker will be required if the atrio-ventricular node is ablated...